World Journal of Hepatology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 39

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6445)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

535

HTML

3721

Figures (1-2)

202

Tables (1-2)

134

Sum=4592

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

913

Download

940

Sum=1853

Oct 21, 2013 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (29)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Ye XG, Su QM. Effects of entecavir and lamivudine for hepatitis B decompensated cirrhosis: Meta-analysis. World J Gastroenterol 2013; 19(39): 6665-6678 [PMID: 24151397 DOI: 10.3748/wjg.v19.i39.6665]
URL:	https://www.wjgnet.com/1948-5182/full/v19/i39/6665.htm

Number	Citing Articles
1	Pietro Lampertico, Kosh Agarwal, Thomas Berg, Maria Buti, Harry L.A. Janssen, George Papatheodoridis, Fabien Zoulim, Frank Tacke. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. Journal of Hepatology 2017; 67(2): 370 doi: 10.1016/j.jhep.2017.03.021
2	Gaeun Kim, Soon Koo Baik. Overview and recent trends of systematic reviews and meta-analyses in hepatology. Clinical and Molecular Hepatology 2014; 20(2): 137 doi: 10.3350/cmh.2014.20.2.137
3	JinSong Geng, HaiNi Bao, YaLan Chen, LiLi Shi, Jing Geng, Qing Wang, Hao Yu. Nucleos(t)ide analogues for the treatment of chronic hepatitis B: a systematic review with network meta-analysis. Expert Review of Anti-infective Therapy 2020; 18(8): 823 doi: 10.1080/14787210.2020.1760843
4	Yiqi Yu, Jingwen Ai, Wenhong Zhang. Current clinical evidence for nucleos(t)ide analogues in patients with HBV-related hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2017; 11(10): 925 doi: 10.1080/17474124.2017.1343665
5	Bipindra Pandey, Rishiram Baral, Atisammodavardhana Kaundinnyayana, Sushil Panta. Promising hepatoprotective agents from the natural sources: a study of scientific evidence. Egyptian Liver Journal 2023; 13(1) doi: 10.1186/s43066-023-00248-w
6	HAO ZHANG, YUCHEN ZHOU, GUOSHENG YUAN, GUANGYAO ZHOU, DINGHUA YANG, YUANPING ZHOU. Antiviral therapy improves the survival rate and decreases recurrences and fatalities in liver cancer patients following curative resection: A meta-analysis. Molecular and Clinical Oncology 2015; 3(6): 1239 doi: 10.3892/mco.2015.614
7	Evangelos Cholongitas, Konstantinos Tziomalos, Chrysoula Pipili. Management of patients with hepatitis B in special populations. World Journal of Gastroenterology 2015; 21(6): 1738-1748 doi: 10.3748/wjg.v21.i6.1738 Abstract(972) \| Core Tip(839) \| Full Article(HTML)(4882) \| Full Article (PDF)-1277K(925) \| Full Article (Word)-335K(466) \| Peer-Review Report-111K(265) \| Answering Reviewers-177K(199) \| Times Cited (35) \| Total Visits (11203) \| Open
8	Christoph Höner zu Siederdissen, Markus Cornberg. Management of HBV and HBV/HDV-Associated Liver Cirrhosis. Visceral Medicine 2016; 32(2): 86 doi: 10.1159/000445518
9	Teng-Yu Lee, Chi-Yi Chen, Hsueh-Chou Lia, Yu-Chung Hsu, Sheng-Shun Yang. The Ultra-Short Virological Dynamics in Response to Entecavir or Lamivudine during Chronic Hepatitis B with Spontaneous Severe Acute Exacerbation. Antiviral Therapy 2018; 23(1): 77 doi: 10.3851/IMP3183
10	Daniel Shouval. The pros and cons of lamivudine vs. entecavir in decompensated or severe acute exacerbation of chronic hepatitis B. Journal of Hepatology 2014; 60(6): 1108 doi: 10.1016/j.jhep.2014.03.004
11	Yuanyuan Kong, Tingting Lv, Min Li, Lianghui Zhao, Tongtong Meng, Shanshan Wu, Wei Wei, Qian Zhang, Sha Chen, Hong You, Sabela Lens, Hitoshi Yoshiji, Sven Francque, Emmanouil Tsochatzis, Shiv K. Sarin, Mattias Mandorfer, Jidong Jia. Systematic review and meta-analysis: impact of anti-viral therapy on portal hypertensive complications in HBV patients with advanced chronic liver disease. Hepatology International 2022; 16(5): 1052 doi: 10.1007/s12072-022-10369-w
12	Lai Wei, Jia-Horng Kao. Benefits of long-term therapy with nucleos(t)ide analogues in treatment-naïve patients with chronic hepatitis B. Current Medical Research and Opinion 2017; 33(3): 495 doi: 10.1080/03007995.2016.1264932
13	Chrysoula Pipili, Evangelos Cholongitas. Μanagement of patients with hepatitis B and C before and after liver and kidney transplantation. World Journal of Hepatology 2014; 6(5): 315-325 doi: 10.4254/wjh.v6.i5.315 Abstract(782) \| Core Tip(871) \| Full Article(HTML)(3186) \| Full Article (PDF)-951K(559) \| Full Article (Word)-263K(314) \| Peer-Review Report-76K(222) \| Answering Reviewers-144K(163) \| Times Cited (10) \| Total Visits (7664) \| Open
14	Hiroshi KAKUTO, Genki SHIMIZU, Denichiro YAMAOKA. <b>A Case of Refractory Ascites with Liver Cirrhosis Successfully Treated by the Combination of Inchinkoto and Goreisan (Inchinkoto-Go-Goreisan)</b>. Kampo Medicine 2015; 66(4): 337 doi: 10.3937/kampomed.66.337
15	Norah A. Terrault, Natalie H. Bzowej, Kyong‐Mi Chang, Jessica P. Hwang, Maureen M. Jonas, M. Hassan Murad. AASLD guidelines for treatment of chronic hepatitis B. Hepatology 2016; 63(1): 261 doi: 10.1002/hep.28156
16	Andreas Krause, Uwe Haberkorn, Walter Mier. Strategies for the treatment of HBV/HDV. European Journal of Pharmacology 2018; 833: 379 doi: 10.1016/j.ejphar.2018.06.030
17	Zhuo-Lun Song, Yu-Jun Cui, Wei-Ping Zheng, Da-Hong Teng, Hong Zheng. Application of nucleoside analogues to liver transplant recipients with hepatitis B. World Journal of Gastroenterology 2015; 21(42): 12091-12100 doi: 10.3748/wjg.v21.i42.12091 Abstract(1037) \| Core Tip(998) \| Full Article(HTML)(3890) \| Full Article (PDF)-1175K(576) \| Full Article (Word)-186K(352) \| Peer-Review Report-111K(210) \| Answering Reviewers-93K(336) \| Times Cited (8) \| Total Visits (11212) \| Open
18	Wei-Lun Tsai, Wei-Chi Sun, Jin-Shiung Cheng. Chronic Hepatitis B with Spontaneous Severe Acute Exacerbation. International Journal of Molecular Sciences 2015; 16(12): 28126 doi: 10.3390/ijms161226087
19	Young-Cheol Ju, Dae-Won Jun, Jun Choi, Waqar Khalid Saeed, Hyo-Young Lee, Hyun-Woo Oh. Long term outcome of antiviral therapy in patients with hepatitis B associated decompensated cirrhosis. World Journal of Gastroenterology 2018; 24(40): 4606-4614 doi: 10.3748/wjg.v24.i40.4606 Abstract(833) \| Core Tip(729) \| Full Article(HTML)(3364) \| Full Article (PDF)-1286K(600) \| Full Article (Word)-561K(426) \| Audio-2020K(10) \| Peer-Review Report-242K(215) \| Answering Reviewers-88K(197) \| Times Cited (10) \| Total Visits (12207) \| Open
20	Wan Yue-Meng, Yu-Hua Li, Hua-Mei Wu, Jing Yang, Ying Xu, Li-Hong Yang, Jin-Hui Yang. Telbivudine versus lamivudine and entecavir for treatment-naïve decompensated hepatitis B virus-related cirrhosis. Clinical and Experimental Medicine 2017; 17(2): 233 doi: 10.1007/s10238-016-0420-7
21	Li Xie, Juan Yin, Ruyi Xia, Guihua Zhuang. Cost‐effectiveness of antiviral treatment after resection in hepatitis B virus–related hepatocellular carcinoma patients with compensated cirrhosis. Hepatology 2018; 68(4): 1476 doi: 10.1002/hep.29922
22	Norah A. Terrault, Anna S.F. Lok, Brian J. McMahon, Kyong‐Mi Chang, Jessica P. Hwang, Maureen M. Jonas, Robert S. Brown, Natalie H. Bzowej, John B. Wong. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 2018; 67(4): 1560 doi: 10.1002/hep.29800
23	Lemonica Koumbi. Current and future antiviral drug therapies of hepatitis B chronic infection. World Journal of Hepatology 2015; 7(8): 1030-1040 doi: 10.4254/wjh.v7.i8.1030 Abstract(801) \| Core Tip(733) \| Full Article(HTML)(3545) \| Full Article (PDF)-1020K(445) \| Full Article (Word)-216K(270) \| Peer-Review Report-138K(164) \| Answering Reviewers-110K(180) \| Times Cited (45) \| Total Visits (9180) \| Open
24	Xiaoli Fan, Liyu Chen, Jingyu Yang, Ping Feng. Entecavir-Associated Thrombocytopenia in a Decompensated Cirrhotic Patient. Medicine 2016; 95(12): e3103 doi: 10.1097/MD.0000000000003103
25	F.Y. Wang, B. Li, Y. Li, H. Liu, W.D. Qu, H.W. Xu, J.N. Qi, C.Y. Qin. Entecavir for Patients with Hepatitis B Decompensated Cirrhosis in China: a meta-analysis. Scientific Reports 2016; 6(1) doi: 10.1038/srep32722
26	James Fung, Ching-Lung Lai, Man-Fung Yuen. Management of chronic hepatitis B in severe liver disease. World Journal of Gastroenterology 2014; 20(43): 16053-16061 doi: 10.3748/wjg.v20.i43.16053 Abstract(732) \| Core Tip(681) \| Full Article(HTML)(3139) \| Full Article (PDF)-702K(376) \| Full Article (Word)-166K(192) \| Peer-Review Report-142K(172) \| Answering Reviewers-33K(167) \| Times Cited (15) \| Total Visits (8004) \| Open
27	Tsung-Hsing Hung, Chih-Chun Tsai, Hsing-Feng Lee. Population-based study of Entecavir and long-term mortality in chronic hepatitis B–related decompensated liver cirrhosis. Clinics and Research in Hepatology and Gastroenterology 2019; 43(6): 694 doi: 10.1016/j.clinre.2019.02.010
28	You-Wen Tan, Yun Ye, Guo-Hong Ge, Wei Zhao, Jian-He Gan, Yun Zhao, Zhi-Lin Niu, Dong-Jun Zhang, Li Chen, Xue-Jun Yu, Li-Jun Yang. Natural YMDD-motif mutants affect clinical course of lamivudine in chronic hepatitis B. World Journal of Gastroenterology 2015; 21(7): 2089-2095 doi: 10.3748/wjg.v21.i7.2089 Abstract(1177) \| Core Tip(808) \| Full Article(HTML)(3058) \| Full Article (PDF)-845K(544) \| Full Article (Word)-313K(280) \| Peer-Review Report-144K(222) \| Answering Reviewers-90K(173) \| Times Cited (7) \| Total Visits (9319) \| Open
29	Anil Arora, Anil C. Anand, Ashish Kumar, Shivaram P. Singh, Rakesh Aggarwal, Radha K. Dhiman, Shyam Aggarwal, Seema Alam, Pradeep Bhaumik, Vinod K. Dixit, Ashish Goel, Bhabadev Goswami, Ashok Kumar, Manoj Kumar, Kaushal Madan, Natarajan Murugan, Aabha Nagral, Amarender S. Puri, Padaki N. Rao, Neeraj Saraf, Vivek A. Saraswat, Sanjeev Sehgal, Praveen Sharma, Koticherry T. Shenoy, Manav Wadhawan. INASL Guidelines on Management of Hepatitis B Virus Infection in Patients receiving Chemotherapy, Biologicals, Immunosupressants, or Corticosteroids. Journal of Clinical and Experimental Hepatology 2018; 8(4): 403 doi: 10.1016/j.jceh.2018.06.010